VYEPTI 300 mg concentrate for solution for infusion | medicines.ie

Company: Lundbeck (Ireland) Limited
Active Ingredient: Eptinezumab
Strength: Eptinezumab: 300 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Loading the document

Lundbeck (Ireland) Limited

4045 Kingswood Road, Citywest Business Park, Co Dublin, Ireland

Telephone: +441908638972
Email: ukinfo@lundbeck.com